Diagnosis of cutaneous mucormycosis due to Rhizopus microsporus by an innovative PCR-restriction fragment-length polymorphism method [4]

Clinical Infectious Diseases

Volumn 41, Issue 9, 2005, Pages 1362-1365

  Larché, Jérôme ^a   Machouart, M ^a   Burton, K ^a   Collomb, J ^a   Biava, M F ^a   Gerard A ^a   Fortier, B ^a  

^a CHU NANCY BRABOIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX;

ADULT; CASE REPORT; FEMALE; HUMAN; LETTER; LYMPHOMA; MUCORMYCOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RHIZOPUS; RHIZOPUS MICROSPORUS; SEPTIC SHOCK; SKIN NECROSIS;

EID: 27444441672     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/497078     Document Type: Letter

References (12)

1. Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev 2000; 13:236-301.
2. Lucas JB, Salver RD, Watson DW. Gangrenous primary cutaneous mucormycosis of the scalp in an iatrogenically immunosuppressed trauma patient. Otolaryngol Head Neck Surg 2003; 128:912-4.
3. Cuvelier I, Vogelaers D, Peleman R, et al. Two cases of disseminated mucormycosis in patients with hematological malignancies and literature review. Eur J Clin Microbiol Infect Dis 1998; 17:859-63.
4. Eucker J, Sezr O, Graf B, Possinger K. Mucormycoses. Mycoses 2001; 44:253-60.
5. Nucci M. Emerging moulds: Fusarium, Scedosporium and Zygomycetes in transplant recipients. Curr Opin Infect Dis 2003; 16:607-12.
6. Bottone EJ, Weitzman I, Hanna BA. Rhizopus rhizopodiformis: emerging etiological agent of mucormycosis. J Clin Microbiol 1979; 9:530-7.
7. Schipper MA, Maslen MM, Hogg GG, Chow CW, Samson RA. Human infection by Rhizopus azygosporus and the occurrence of azygospores in Zygomycetes. J Med Vet Mycol 1996; 34:199-203.
8. Imhof A, Balajee SA, Fredericks DN, Englund JA, Marr KA. Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole. Clin Infect Dis 2004; 39:743-6.
9. Siwek GT, Dodgson KJ, de Magalhaes-Silverman M, et al. Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis. Clin Infect Dis 2004; 39:584-7.
10. Dannaoui E, Meletiadis J, Mouton JW, et al. In vitro susceptibilities of Zygomycetes to conventional and new antifungals. J Antimicrob Chemother 2003; 51:45-52.
11. Kobayashi M, Togitani K, Machida H, et al. Molecular polymerase chain reaction diagnosis of pulmonary mucormycosis caused by Cunninghamella bertholletiae. Respirology 2004; 9:397-401.
12. Kontoyiannis DP, Lionakis MS, Lewis RE, et al. Zygomycosis in a tertiary-care cancer center in the era of Aspergillus active antifungal therapy: a case control observational study of 27 recent cases. J Infect Dis 2005; 191:1350-60.